FSD Pharma Inc Előre P/E
Mi az FSD Pharma Inc Előre P/E?
A Előre P/E az FSD Pharma Inc - N/A
Mi a Előre P/E meghatározása?
Az előrejelzett ár / jövedelem arány a vállalat tőzsdei árának és a társaság becsült részvényenkénti eredményének aránya a következő tizenkét hónapban.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Mit csinál FSD Pharma Inc?
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.